IGF2BP2 is downregulated in several tumours, including breast‐invasive carcinoma, adrenocortical carcinoma, pheochromocytoma and ccRCC according to TCGA database. This evidence concerns the gene IGF2BP2 and hereditary pheochromocytoma-paraganglioma.